Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PON1 | P27169 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2149004 | 0.87 | SMN1; SMN2 (0.42) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL14637454 | 0.87 | SMN1; SMN2 (0.42) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL899263 | 0.87 | SMN1; SMN2 (0.42) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL30785023 | 0.86 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL30427141 | 0.86 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Thiocyanic Acid SCHEMBL294220 | 0.86 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL665752 | 0.86 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL897977 | 0.86 | SMN1; SMN2 (0.41) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL15734074 | 0.85 | SMN1; SMN2 (0.46) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Cyanate SCHEMBL14894995 | 0.85 | SMN1; SMN2 (0.46) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 598 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12490644-B2 | Solar cell upper electrode and manufacturing method therefor | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-12-02 | — | — | US | claimed |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| US-20240337641-A1 | STRAIN SENSOR FOR MONITORING PLANT ELONGATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2024-10-10 | — | — | US | claimed |
| US-20240304737-A1 | SOLAR CELL UPPER ELECTRODE AND MANUFACTURING METHOD THEREFOR | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-09-12 | — | — | US | claimed |
| CN-116168892-A | Stretchable conductive material and preparation method and device thereof | 臻鼎科技股份有限公司 | 2023-05-26 | — | — | CN | claimed |
| US-20230159749-A1 | STRETCHABLE ELECTROCONDUCTIVE MATERIAL, METHOD FOR MANUFACTURING THE SAME, AND DEVICE USING THE STRETCHABLE ELECTROCONDUCTIVE MATERIAL | Zhen Ding Technology Co., Ltd. (TW) | 2023-05-25 | — | — | US | claimed |
| US-11634370-B2 | Selective hydrogenation methods | CLARIANT INTERNATIONAL LTD (CH) | 2023-04-25 | — | — | US | claimed |
| US-11623902-B2 | Selective hydrogenation methods and catalysts | CLARIANT INTERNATIONAL LTD (CH) | 2023-04-11 | — | — | US | claimed |
| US-20230054698-A1 | SOLAR CELL UPPER ELECTRODE AND MANUFACTURING METHOD THEREFOR | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-02-23 | — | — | US | claimed |
| EP-2606491-A1 | FILMS CONTAINING ELECTRICALLY CONDUCTIVE POLYMERS | Rhodia Operations (FR) | 2013-06-26 | — | — | EP | claimed |
| EP-2606530-A2 | POLYMER COMPOSITIONS, POLYMER FILMS, POLYMER GELS, POLYMER FOAMS, AND ELECTRONIC DEVICES CONTAINING SUCH FILMS, GELS, AND FOAMS | Rhodia Operations (FR) | 2013-06-26 | — | — | EP | claimed |
| US-20130102819-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT CORPORATION | 2013-04-25 | — | — | US | claimed |
| EP-2583751-A1 | Catalyst composition for selective hydrogenation with improved characteristics | Clariant Produkte (Deutschland) GmbH (DE) | 2013-04-24 | — | — | EP | claimed |
| US-20120052395-A1 | Polymer compositions, polymer films, polymer gels, polymer foams, and electronic devices containing such films, gels and foams | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-03-01 | — | — | US | claimed |
| WO-2012023992-A1 | FILMS CONTAINING ELECTRICALLY CONDUCTIVE POLYMERS | RHODIA OPERATIONS (FR) | 2012-02-23 | — | — | WO | claimed |
| WO-2012023989-A2 | POLYMER COMPOSITIONS, POLYMER FILMS, POLYMER GELS, POLYMER FOAMS, AND ELECTRONIC DEVICES CONTAINING SUCH FILMS, GELS, AND FOAMS | RHODIA OPERATIONS (FR) | 2012-02-23 | — | — | WO | claimed |
| US-20120043530-A1 | Polymer compositions, polymer films, polymer gels, polymer foams, and electronic devices containing such films, gels and foams | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-02-23 | — | — | US | claimed |
| US-20110214739-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND METHOD OF MANUFACTURING THE SAME, AND ELECTRONIC APPARATUS | SONY CORPORATION (JP) | 2011-09-08 | — | — | US | claimed |
| EP-2363869-A2 | Photoelectric conversion element and method of manufacturing the same, and electronic apparatus | Sony Corporation (JP) | 2011-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | SMN1; SMN2 3463/4885MEN1 2422/4885APAF1 1509/4885 |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | SMN1; SMN2 3463/4885MEN1 2422/4885APAF1 1509/4885 |
| US-11634370-B2 | Selective hydrogenation methods | KAT8, KAT7, TDO2 | SMN1; SMN2 3566/4885MEN1 3450/4885APAF1 2263/4885 |
| US-11623902-B2 | Selective hydrogenation methods and catalysts | KAT8, ITGAV, ASNS | SMN1; SMN2 3717/4885MEN1 3316/4885APAF1 3350/4885 |
| US-20130102819-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | BET1, EP300, H1-2 | SMN1; SMN2 3633/4885MEN1 2439/4885APAF1 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.